H. Spaar

922 total citations
35 papers, 548 citations indexed

About

H. Spaar is a scholar working on Public Health, Environmental and Occupational Health, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, H. Spaar has authored 35 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Surgery and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in H. Spaar's work include Acute Lymphoblastic Leukemia research (14 papers), Testicular diseases and treatments (11 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). H. Spaar is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Testicular diseases and treatments (11 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). H. Spaar collaborates with scholars based in Germany, Austria and United States. H. Spaar's co-authors include U. Göbel, Norbert Jorch, Gritta Janka‐Schaub, Ulrike Graubner, D. Harms, P. Gutjahr, Gabriele Calaminus, R. Haas, Gertjan J.L. Kaspers and A. Veerman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

H. Spaar

33 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Spaar Germany 13 268 155 143 139 124 35 548
H. Gadner Austria 13 233 0.9× 147 0.9× 145 1.0× 259 1.9× 93 0.8× 39 608
P. Steinherz United States 8 223 0.8× 154 1.0× 134 0.9× 72 0.5× 74 0.6× 14 648
Masaaki Kumagai Japan 12 301 1.1× 242 1.6× 156 1.1× 53 0.4× 93 0.8× 28 633
C Béhar France 12 150 0.6× 182 1.2× 80 0.6× 37 0.3× 65 0.5× 34 421
J.C. Gentet France 11 148 0.6× 61 0.4× 99 0.7× 84 0.6× 121 1.0× 20 614
Federico Sackmann Muriel Argentina 12 156 0.6× 102 0.7× 65 0.5× 55 0.4× 42 0.3× 21 438
RC Ribeiro United States 12 434 1.6× 423 2.7× 172 1.2× 35 0.3× 142 1.1× 20 749
A Ferster Belgium 12 228 0.9× 237 1.5× 143 1.0× 59 0.4× 246 2.0× 28 631
Meerim Park South Korea 16 77 0.3× 191 1.2× 78 0.5× 108 0.8× 90 0.7× 49 521
K. K. Matthay United States 11 99 0.4× 59 0.4× 102 0.7× 83 0.6× 217 1.8× 26 630

Countries citing papers authored by H. Spaar

Since Specialization
Citations

This map shows the geographic impact of H. Spaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Spaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Spaar more than expected).

Fields of papers citing papers by H. Spaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Spaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Spaar. The network helps show where H. Spaar may publish in the future.

Co-authorship network of co-authors of H. Spaar

This figure shows the co-authorship network connecting the top 25 collaborators of H. Spaar. A scholar is included among the top collaborators of H. Spaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Spaar. H. Spaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spaar, H., J. Michaelis, D Niethammer, et al.. (2008). Bedeutung der präoperativen Chemotherapie und der Radiotherapie bei 373 Kindern mit Wilms-Tumor*. DMW - Deutsche Medizinische Wochenschrift. 115(7). 248–253.
2.
Escherich, Gabriele, U. Göbel, Norbert Jorch, H. Spaar, & Gritta Janka‐Schaub. (2007). Daunorubicin-Induced Cell Kill with 1-Hour Versus 24-Hour Infusions: A Randomized Comparison in Children with Newly Diagnosed Acute Lymphoblastic Leukemia. Klinische Pädiatrie. 219(3). 134–138. 11 indexed citations
3.
Boer, Monique L. den, D. Harms, Rob Pieters, et al.. (2003). Patient Stratification Based on Prednisolone-Vincristine-Asparaginase Resistance Profiles in Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 21(17). 3262–3268. 133 indexed citations
4.
Creutzig, Ursula, Frank Berthold, Joachim Boos, et al.. (2001). Verbesserung der Prognose bei Kindern mit AML: Ergebnisse der Studie AML-BFM 931. Klinische Pädiatrie. 213(4). 175–185. 15 indexed citations
5.
Stadt, Udo zur, D. Harms, Martin Schrappe, et al.. (2001). MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen. Leukemia. 15(2). 283–285. 22 indexed citations
6.
Stadt, Udo zur, D. Harms, Norbert Jorch, et al.. (2000). Minimal Residual Disease Untersuchungen bei der akuten lymphatischen Leukämie im Kindesalter im Rahmen der COALL-Studie: Ergebnisse einer Induktionstherapie ohne Asparaginase. Klinische Pädiatrie. 212(4). 169–173. 5 indexed citations
7.
Kaspers, Gertjan J.L., A. Veerman, Marianne G. Rots, et al.. (1999). Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study. Klinische Pädiatrie. 211(4). 239–244. 26 indexed citations
8.
Graubner, Ulrike, Ursula Creutzig, Yvonne Dörffel, et al.. (1999). Die antiinfektiöse Prophylaxe in der pädiatrischen Onkologie. Klinische Pädiatrie. 211(4). 347–352. 2 indexed citations
9.
Janka‐Schaub, G., D. Harms, Ulrich Goebel, et al.. (1996). Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood — follow up after 9 years. European Journal of Pediatrics. 155(8). 640–648. 13 indexed citations
10.
11.
Janka‐Schaub, Gritta, et al.. (1991). Initiales Ansprechen auf die Therapie als wichtigster prognostischer Faktor bei der akuten lymphoblastischen Leukämie im Kindesalter. Klinische Pädiatrie. 203(4). 231–235. 3 indexed citations
12.
Göbel, U., M. Bamberg, J. Engert, et al.. (1991). Die Behandlung nichttestikulärer Keimzelltumoren bei Kindern und Jugendlichen mit BEP und VIP: Erste Ergebnisse der Therapiestudie MAKEI 89. Klinische Pädiatrie. 203(4). 236–245. 3 indexed citations
13.
Janka‐Schaub, G., Ulrich Goebel, Ulrike Graubner, et al.. (1990). Improved Prognosis for Childhood Acute Lymphocytic Leukemia with Very High White Blood Cell Count (> 100/nl) with Rotation of Non-Cross-Resistant Drug Combinations. Hämatologie und Bluttransfusion. 33. 489–493. 2 indexed citations
14.
Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations
15.
Treuner, J., Joachim Kühl, Jörn‐Dirk Beck, et al.. (1989). New Aspects in the Treatment of Childhood Rhabdomyosarcoma: Results of the German Cooperative Soft-Tissue Sarcoma Study (CWS-81). PubMed. 22. 162–175. 8 indexed citations
16.
Göbel, U., M. Bamberg, Volker Budach, et al.. (1989). Intracraniale Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 261–268. 8 indexed citations
17.
Stienen, Ulrich, Peter Kaatsch, D. Harms, et al.. (1986). Analyse prognostischer Faktoren beim Rhabdomyosarkom. Klinische Pädiatrie. 198(3). 218–223. 5 indexed citations
18.
Janka, Gritta, et al.. (1986). Akute lymphoblastische Leukämie im Kindesalter: Die COALL-Studien*. Klinische Pädiatrie. 198(3). 171–177. 12 indexed citations
19.
Göbel, U., W. Brandeis, H. Gadner, et al.. (1985). Preliminary Results of the GPO-Trial for Treatment of Non-Testicular Germ-Cell Tumors in Children and Adolescents. Oncology Research and Treatment. 8(3). 178–180. 2 indexed citations
20.
Müller-Weihrich, St., Jörn D. Beck, G. Henze, et al.. (1984). BFM-Studie 1981/83 zur Behandlung hochmaligner Non-Hodgkin-Lymphome bei Kindern: Ergebnisse einer nach histologisch-immunologischem Typ und Ausbreitungsstadium stratefizierten Therapie. Klinische Pädiatrie. 196(3). 135–142. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Gadner Breakdown of academic impact, for papers by P. Steinherz Breakdown of academic impact, for papers by Masaaki Kumagai Breakdown of academic impact, for papers by C Béhar Breakdown of academic impact, for papers by J.C. Gentet Breakdown of academic impact, for papers by Federico Sackmann Muriel Breakdown of academic impact, for papers by RC Ribeiro Breakdown of academic impact, for papers by A Ferster Breakdown of academic impact, for papers by Meerim Park Breakdown of academic impact, for papers by K. K. Matthay
Rankless by CCL
2026